{"transactions":[{"id":1136876,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-05-22T20:05:43.000Z","date":"2025-05-20","kind":"sale","planned":false,"acquired":false,"shares":767,"price":6.446,"value":4944.082,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":441927,"source":{"system":"sec-edgar","filing":"0001140361-25-020161","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125020161/form4.xml","form_type":"4"}},{"id":1140281,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-05-20T20:05:44.000Z","date":"2025-05-16","kind":"sale","planned":false,"acquired":false,"shares":1409,"price":6.528,"value":9197.952,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":442694,"source":{"system":"sec-edgar","filing":"0001140361-25-019901","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125019901/form4.xml","form_type":"4"}},{"id":1173892,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-04-10T20:07:53.000Z","date":"2025-04-09","kind":"purchase","planned":false,"acquired":true,"shares":21099,"price":4.7,"value":99165.3,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 9, 2025, the Reporting Person's husband purchased 21,099 shares of Common Stock in a series of brokered transactions at prices ranging from $4.65 to $4.78 and a weighted average price per share of $4.70 (rounded to two decimal places), for an aggregate purchase price of approximately $99,157. The detailed breakdown of executed sales will be furnished upon request."}],"balance_after":26774,"source":{"system":"sec-edgar","filing":"0001140361-25-013253","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125013253/form4.xml","form_type":"4"}},{"id":1245699,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-25T21:01:58.000Z","date":"2025-02-21","kind":"sale","planned":false,"acquired":false,"shares":6078,"price":10.58,"value":64305.24,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":444103,"source":{"system":"sec-edgar","filing":"0001140361-25-005847","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125005847/form4.xml","form_type":"4"}},{"id":1269451,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-13T21:01:32.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":172214,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option represents a right to purchase a total of 172,214 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 11, 2026, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":172214,"derivative":{"exercise_price":9.88,"expiration_date":"2035-02-11","underlying":"Common Stock","underlying_shares":172214},"source":{"system":"sec-edgar","filing":"0001140361-25-004294","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125004294/form4.xml","form_type":"4"}},{"id":1269450,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-13T21:01:32.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":57786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represent RSUs that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on February 11, 2026, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":450181,"source":{"system":"sec-edgar","filing":"0001140361-25-004294","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125004294/form4.xml","form_type":"4"}},{"id":1352534,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-11-25T21:05:18.000Z","date":"2024-11-21","kind":"sale","planned":false,"acquired":false,"shares":4588,"price":13.054,"value":59891.752,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":392395,"source":{"system":"sec-edgar","filing":"0001140361-24-047756","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124047756/form4.xml","form_type":"4"}},{"id":1427479,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-08-20T20:26:47.000Z","date":"2024-08-16","kind":"sale","planned":false,"acquired":false,"shares":3989,"price":18.504,"value":73812.456,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":396983,"source":{"system":"sec-edgar","filing":"0001140361-24-037933","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124037933/form4.xml","form_type":"4"}},{"id":1508801,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2024-05-20T20:26:25.000Z","date":"2023-02-14","kind":"other","planned":false,"acquired":false,"shares":38735,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":38735},"source":{"system":"sec-edgar","filing":"0001140361-24-026871","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124026871/form4.xml","form_type":"4"}},{"id":1508800,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2024-05-20T20:26:25.000Z","date":"2022-08-12","kind":"other","planned":false,"acquired":false,"shares":52489,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Represents RSUs initially granted on August 12, 2022, which vest in full on August 12, 2025."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents RSUs initially granted on August 12, 2022, which vest in full on August 12, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Represents RSUs initially granted on August 12, 2022, which vest in full on August 12, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":52489},"source":{"system":"sec-edgar","filing":"0001140361-24-026871","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124026871/form4.xml","form_type":"4"}},{"id":1508799,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2024-05-20T20:26:25.000Z","date":"2022-02-14","kind":"other","planned":false,"acquired":false,"shares":11970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents RSUs initially granted on February 14, 2022. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents RSUs initially granted on February 14, 2022. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents RSUs initially granted on February 14, 2022. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11970},"source":{"system":"sec-edgar","filing":"0001140361-24-026871","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124026871/form4.xml","form_type":"4"}},{"id":1508798,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2024-05-20T20:26:25.000Z","date":"2024-05-14","kind":"exercise","planned":false,"acquired":false,"shares":5533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":38735,"derivative":{"underlying":"Common Stock","underlying_shares":5533},"source":{"system":"sec-edgar","filing":"0001140361-24-026871","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124026871/form4.xml","form_type":"4"}},{"id":1508797,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2024-05-20T20:26:25.000Z","date":"2024-05-14","kind":"exercise","planned":false,"acquired":false,"shares":3990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents RSUs initially granted on February 14, 2022. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents RSUs initially granted on February 14, 2022. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents RSUs initially granted on February 14, 2022. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":11970,"derivative":{"underlying":"Common Stock","underlying_shares":3990},"source":{"system":"sec-edgar","filing":"0001140361-24-026871","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124026871/form4.xml","form_type":"4"}},{"id":1508796,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-05-20T20:26:25.000Z","date":"2024-05-16","kind":"sale","planned":false,"acquired":false,"shares":4046,"price":23.35,"value":94474.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":400972,"source":{"system":"sec-edgar","filing":"0001140361-24-026871","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124026871/form4.xml","form_type":"4"}},{"id":1508795,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-05-20T20:26:25.000Z","date":"2023-02-14","kind":"other","planned":false,"acquired":true,"shares":38735,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"security","element":"securityTitle","label":"F3","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."}],"balance_after":405018,"source":{"system":"sec-edgar","filing":"0001140361-24-026871","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124026871/form4.xml","form_type":"4"}},{"id":1508794,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-05-20T20:26:25.000Z","date":"2022-08-12","kind":"other","planned":false,"acquired":true,"shares":52489,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"security","element":"securityTitle","label":"F4","text":"Represents RSUs initially granted on August 12, 2022, which vest in full on August 12, 2025."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."}],"balance_after":366283,"source":{"system":"sec-edgar","filing":"0001140361-24-026871","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124026871/form4.xml","form_type":"4"}},{"id":1508793,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-05-20T20:26:25.000Z","date":"2022-02-14","kind":"other","planned":false,"acquired":true,"shares":11970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents RSUs initially granted on February 14, 2022. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"security","element":"securityTitle","label":"F3","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."}],"balance_after":313794,"source":{"system":"sec-edgar","filing":"0001140361-24-026871","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124026871/form4.xml","form_type":"4"}},{"id":1508792,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-05-20T20:26:25.000Z","date":"2024-05-14","kind":"exercise","planned":false,"acquired":true,"shares":5553,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":301824,"source":{"system":"sec-edgar","filing":"0001140361-24-026871","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124026871/form4.xml","form_type":"4"}},{"id":1508791,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-05-20T20:26:25.000Z","date":"2024-05-14","kind":"exercise","planned":false,"acquired":true,"shares":3990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents RSUs initially granted on February 14, 2022. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":296291,"source":{"system":"sec-edgar","filing":"0001140361-24-026871","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124026871/form4.xml","form_type":"4"}},{"id":1628583,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-22T01:54:35.000Z","date":"2024-02-16","kind":"grant","planned":false,"acquired":true,"shares":98183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option represents a right to purchase a total of 98,183 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 16, 2025, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":98183,"derivative":{"exercise_price":30.01,"expiration_date":"2034-02-16","underlying":"Common Stock","underlying_shares":98183},"source":{"system":"sec-edgar","filing":"0001140361-24-008889","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124008889/form4.xml","form_type":"4"}},{"id":1628582,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-22T01:54:35.000Z","date":"2024-02-16","kind":"grant","planned":false,"acquired":true,"shares":33288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares beneficially owned by the reporting person are subject to a lock-up agreement dated September 12, 2023 (the \"Lock-Up Agreement\")."},{"field":"security","element":"securityTitle","label":"F4","text":"Represent RSUs that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on February 16, 2025, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":271634,"source":{"system":"sec-edgar","filing":"0001140361-24-008889","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124008889/form4.xml","form_type":"4"}},{"id":1628581,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-22T01:54:35.000Z","date":"2024-02-16","kind":"sale","planned":false,"acquired":false,"shares":7132,"price":29.838,"value":212804.616,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares beneficially owned by the reporting person are subject to a lock-up agreement dated September 12, 2023 (the \"Lock-Up Agreement\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F3","text":"The shares of common stock were sold by the Reporting Person pursuant to an exemption to the Lock-Up Agreement in order to pay tax withholding obligations in connection with the vesting of RSUs. Notwithstanding the sales reported on this Form 4, the securities beneficially owned by the reporting person remain subject to the terms of the Lock-Up Agreement."}],"balance_after":238346,"source":{"system":"sec-edgar","filing":"0001140361-24-008889","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124008889/form4.xml","form_type":"4"}},{"id":1637977,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2024-02-16T21:05:49.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":false,"shares":22199,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal annual installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal annual installments over the following two years."}],"balance_after":44268,"derivative":{"underlying":"Common Stock","underlying_shares":22199},"source":{"system":"sec-edgar","filing":"0001140361-24-008358","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124008358/form4.xml","form_type":"4"}},{"id":1637976,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2024-02-16T21:05:49.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":false,"shares":3990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal annual installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal annual installments over the following two years."}],"balance_after":15960,"derivative":{"underlying":"Common Stock","underlying_shares":3990},"source":{"system":"sec-edgar","filing":"0001140361-24-008358","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124008358/form4.xml","form_type":"4"}},{"id":1637975,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-16T21:05:49.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":true,"shares":26189,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."}],"balance_after":245478,"source":{"system":"sec-edgar","filing":"0001140361-24-008358","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124008358/form4.xml","form_type":"4"}},{"id":1738888,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-11-17T00:17:35.000Z","date":"2023-11-14","kind":"exercise","planned":false,"acquired":false,"shares":3989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal annual installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal annual installments over the following two years."}],"balance_after":19950,"derivative":{"underlying":"Common Stock","underlying_shares":3989},"source":{"system":"sec-edgar","filing":"0001140361-23-053711","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123053711/form4.xml","form_type":"4"}},{"id":1738887,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-11-17T00:17:35.000Z","date":"2023-11-14","kind":"exercise","planned":false,"acquired":true,"shares":3989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."}],"balance_after":220437,"source":{"system":"sec-edgar","filing":"0001140361-23-053711","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123053711/form4.xml","form_type":"4"}},{"id":1762476,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-10-10T20:11:50.000Z","date":"2023-10-05","kind":"exercise","planned":false,"acquired":false,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Adaptive Technology LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-third (1/3) of such RSUs became fully vested and exercisable on October 5, 2021, with the remaining shares vesting in equal annual installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"One-third (1/3) of such RSUs became fully vested and exercisable on October 5, 2021, with the remaining shares vesting in equal annual installments over the following two years."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held indirectly through Adaptive Technology, LLC, (\"Adaptive Technology\") a limited liability company that is owned and managed by the reporting person's husband. The restricted stock units were granted to Adaptive Technology, in connection with a Consulting Agreement for information technology services provided to the Company."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001140361-23-047589","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123047589/form4.xml","form_type":"4"}},{"id":1762475,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-10-10T20:11:50.000Z","date":"2023-10-05","kind":"exercise","planned":false,"acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Adaptive Technology LLC"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held indirectly through Adaptive Technology, LLC, (\"Adaptive Technology\") a limited liability company that is owned and managed by the reporting person's husband. The restricted stock units were granted to Adaptive Technology, in connection with a Consulting Agreement for information technology services provided to the Company."}],"balance_after":101594,"source":{"system":"sec-edgar","filing":"0001140361-23-047589","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123047589/form4.xml","form_type":"4"}},{"id":1800619,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-08-21T20:05:43.000Z","date":"2023-08-17","kind":"sale","planned":false,"acquired":false,"shares":1534,"price":15.471,"value":23732.514,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person."}],"balance_after":216448,"source":{"system":"sec-edgar","filing":"0001140361-23-040695","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123040695/form4.xml","form_type":"4"}},{"id":1807215,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-08-15T20:16:18.000Z","date":"2023-08-14","kind":"exercise","planned":false,"acquired":false,"shares":3989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":23993,"derivative":{"underlying":"Common Stock","underlying_shares":3989},"source":{"system":"sec-edgar","filing":"0001140361-23-039904","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123039904/form4.xml","form_type":"4"}},{"id":1807214,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-08-15T20:16:18.000Z","date":"2023-08-14","kind":"exercise","planned":false,"acquired":true,"shares":3989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."}],"balance_after":217982,"source":{"system":"sec-edgar","filing":"0001140361-23-039904","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123039904/form4.xml","form_type":"4"}},{"id":1884346,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-05-19T20:05:32.000Z","date":"2023-05-17","kind":"sale","planned":false,"acquired":false,"shares":1330,"price":21.375,"value":28428.75,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person."}],"balance_after":213993,"source":{"system":"sec-edgar","filing":"0001140361-23-025743","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123025743/form4.xml","form_type":"4"}},{"id":1891296,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-05-16T23:57:09.000Z","date":"2023-05-14","kind":"exercise","planned":false,"acquired":false,"shares":3989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":27982,"derivative":{"underlying":"Common Stock","underlying_shares":3989},"source":{"system":"sec-edgar","filing":"0001140361-23-025131","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123025131/form4.xml","form_type":"4"}},{"id":1891295,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-05-16T23:57:09.000Z","date":"2023-05-14","kind":"exercise","planned":false,"acquired":true,"shares":3989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."}],"balance_after":215323,"source":{"system":"sec-edgar","filing":"0001140361-23-025131","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123025131/form4.xml","form_type":"4"}},{"id":1999247,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-02-23T00:25:55.000Z","date":"2023-02-14","kind":"exercise","acquired":true,"shares":15720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The original Form 4, filed on February 16, 2023, is being amended by this amendment to include the vesting of restricted stock units that took place on February 14, 2023."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"One-third (1/3) of such restricted stock units became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"One-third (1/3) of such restricted stock units became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":31917,"derivative":{"underlying":"Common Stock","underlying_shares":15720},"source":{"system":"sec-edgar","filing":"0001140361-23-008100","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123008100/form4.xml","form_type":"4/A","original_submission_date":"2023-02-16"}},{"id":1999246,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-02-23T00:25:55.000Z","date":"2023-02-14","kind":"grant","acquired":true,"shares":66467,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":66467,"derivative":{"underlying":"Common Stock","underlying_shares":66467},"source":{"system":"sec-edgar","filing":"0001140361-23-008100","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123008100/form4.xml","form_type":"4/A","original_submission_date":"2023-02-16"}},{"id":1999245,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-23T00:25:55.000Z","date":"2023-02-14","kind":"grant","acquired":true,"shares":199194,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option represents a right to purchase a total of 199,194 shares of the Issuer's common stock, one-third (1/3) of which will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":199194,"derivative":{"exercise_price":20.04,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":199194},"source":{"system":"sec-edgar","filing":"0001140361-23-008100","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123008100/form4.xml","form_type":"4/A","original_submission_date":"2023-02-16"}},{"id":1999244,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-02-23T00:25:55.000Z","date":"2023-02-14","kind":"exercise","acquired":true,"shares":15720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The original Form 4, filed on February 16, 2023, is being amended by this amendment to include the vesting of restricted stock units that took place on February 14, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit award."}],"balance_after":166566,"source":{"system":"sec-edgar","filing":"0001140361-23-008100","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123008100/form4.xml","form_type":"4/A","original_submission_date":"2023-02-16"}},{"id":2010744,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-02-16T21:45:32.000Z","date":"2023-02-14","kind":"grant","acquired":true,"shares":66467,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":66467,"derivative":{"underlying":"Common Stock","underlying_shares":66467},"source":{"system":"sec-edgar","filing":"0001140361-23-007483","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123007483/form4.xml","form_type":"4"}},{"id":2010743,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-16T21:45:32.000Z","date":"2023-02-14","kind":"grant","acquired":true,"shares":199194,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 199,194 shares of the Issuer's common stock, one-third (1/3) of which will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":199194,"derivative":{"exercise_price":20.04,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":199194},"source":{"system":"sec-edgar","filing":"0001140361-23-007483","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123007483/form4.xml","form_type":"4"}},{"id":2183927,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2022-08-16T21:31:09.000Z","date":"2022-08-12","kind":"grant","acquired":true,"shares":52489,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will become fully vested on August 12, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units will become fully vested on August 12, 2025."}],"balance_after":52489,"derivative":{"underlying":"Common Stock","underlying_shares":52489},"source":{"system":"sec-edgar","filing":"0001140361-22-029892","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036122029892/form4.xml","form_type":"4"}},{"id":2391525,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2022-02-17T02:03:01.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":47637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":47637,"derivative":{"underlying":"Common Stock","underlying_shares":47637},"source":{"system":"sec-edgar","filing":"0001140361-22-005826","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036122005826/form4.xml","form_type":"4"}},{"id":2391524,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-17T02:03:01.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":148518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 148,518 shares of the Issuer's common stock, one-third (1/3) of which will become fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":148518,"derivative":{"exercise_price":20,"expiration_date":"2032-02-13","underlying":"Common Stock","underlying_shares":148518},"source":{"system":"sec-edgar","filing":"0001140361-22-005826","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036122005826/form4.xml","form_type":"4"}},{"id":2770428,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-26T22:17:44.000Z","date":"2021-03-24","kind":"exercise","acquired":false,"shares":38093,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.69,"expiration_date":"2027-04-12","underlying":"Common Sock","underlying_shares":38093},"source":{"system":"sec-edgar","filing":"0001140361-21-010348","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121010348/form4.xml","form_type":"4"}},{"id":2770427,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-26T22:17:44.000Z","date":"2021-03-24","kind":"exercise","acquired":false,"shares":55869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.21,"expiration_date":"2026-04-18","underlying":"Common Sock","underlying_shares":55869},"source":{"system":"sec-edgar","filing":"0001140361-21-010348","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121010348/form4.xml","form_type":"4"}},{"id":2770426,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-03-26T22:17:44.000Z","date":"2021-03-24","kind":"exercise","acquired":true,"shares":38093,"price":1.69,"value":64377.17,"ownership":{"direct":true},"balance_after":188939,"source":{"system":"sec-edgar","filing":"0001140361-21-010348","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121010348/form4.xml","form_type":"4"}},{"id":2770425,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-03-26T22:17:44.000Z","date":"2021-03-24","kind":"exercise","acquired":true,"shares":55869,"price":1.21,"value":67601.49,"ownership":{"direct":true},"balance_after":150846,"source":{"system":"sec-edgar","filing":"0001140361-21-010348","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121010348/form4.xml","form_type":"4"}},{"id":2874303,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-09T01:48:09.000Z","date":"2021-02-04","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option represents a right to purchase a total of 120,000 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 4, 2022, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":120000,"derivative":{"exercise_price":62.32,"expiration_date":"2031-02-03","underlying":"Common Sock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001140361-21-003787","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121003787/form4.xml","form_type":"4"}},{"id":2928635,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-12-30T21:50:30.000Z","date":"2020-12-28","kind":"sale","acquired":false,"shares":5427,"price":57.1656,"value":310237.7112,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan dated 10/23/2020 in multiple trades at prices ranging from $56.903 to $57.49. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":94977,"source":{"system":"sec-edgar","filing":"0001140361-20-029917","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036120029917/form4.xml","form_type":"4"}},{"id":2928634,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-12-30T21:50:30.000Z","date":"2020-12-28","kind":"sale","acquired":false,"shares":11334,"price":56.512,"value":640507.008,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan dated 10/23/2020 in multiple trades at prices ranging from $55.90 to $56.86. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":100404,"source":{"system":"sec-edgar","filing":"0001140361-20-029917","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036120029917/form4.xml","form_type":"4"}},{"id":3010755,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2020-10-08T01:18:08.000Z","date":"2020-10-05","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a right to receive one share of RCKT common stock upon satisfaction of vesting conditions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were issued pursuant to the Rocket Pharmaceuticals Inc. 2014 Stock Option and Incentive Plan.  The restricted stock units shall vest in equal annual installments over 3 years from October 5, 2020 (date of grant) subject to continued service through such dates."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The restricted stock units were granted to the reporting person's husband, in connection with a Consulting Agreement for information technology services provided to the Company."}],"balance_after":10000,"derivative":{"expiration_date":"2030-10-05","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001140361-20-022671","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036120022671/form4.xml","form_type":"4"}},{"id":3034250,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-10T20:06:01.000Z","date":"2020-09-08","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option represents a right to purchase a total of 50,000 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on September 8, 2021, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":50000,"derivative":{"exercise_price":23.05,"expiration_date":"2030-09-08","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001140361-20-020136","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036120020136/form4.xml","form_type":"4"}},{"id":3200474,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-03-19T23:56:20.000Z","date":"2020-03-18","kind":"purchase","acquired":true,"shares":1000,"price":9.5,"value":9500.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":6675,"source":{"system":"sec-edgar","filing":"0001140361-20-006375","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036120006375/form4.xml","form_type":"4"}},{"id":3281874,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-10T22:06:56.000Z","date":"2020-02-10","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 15,000 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 10, 2021, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":23.89,"expiration_date":"2030-02-10","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-20-008013","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000120919120008013/doc4.xml","form_type":"4"}},{"id":3281873,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-10T22:06:56.000Z","date":"2020-02-06","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 150,000 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 6, 2021, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":150000,"derivative":{"exercise_price":22.72,"expiration_date":"2030-02-06","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-20-008013","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000120919120008013/doc4.xml","form_type":"4"}},{"id":3423302,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-04T20:22:06.000Z","date":"2019-09-02","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 50,000 shares of the Issuer's Common Stock, 16,672 of which will become fully vested and exercisable on September 2, 2020, with the remaining 33,328 shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":50000,"derivative":{"exercise_price":10.85,"expiration_date":"2029-09-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-19-048188","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000120919119048188/doc4.xml","form_type":"4"}},{"id":3547473,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-26T20:06:34.000Z","date":"2018-08-17","kind":"exercise","acquired":false,"shares":55869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option represents a right to purchase a total of 167,607 shares of the Issuer's Common Stock 56,072 of which became fully vested and exercisable on April 18, 2017, with the remaining 111,535 shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reflects the number of derivative securities beneficially owned following the transaction reported herein. The derivative securities that the reporting person beneficially owned were overstated by 55,869 derivative securities in the reporting person's Form 4 filed on December 21, 2018."}],"balance_after":111738,"derivative":{"exercise_price":1.21,"expiration_date":"2026-04-18","underlying":"Common Stock","underlying_shares":55869},"source":{"system":"sec-edgar","filing":"0001140361-19-007695","document":"form5.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036119007695/form5.xml","form_type":"5"}},{"id":3547472,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-04-26T20:06:34.000Z","date":"2018-08-17","kind":"exercise","acquired":true,"shares":55869,"price":1.21,"value":67601.49,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the total number of shares owned by the reporting person as of December 31, 2018 and as of the date hereof. The reporting person inadvertently failed to previously report the transaction reported herein. As a result, the shares that the reporting person held directly were understated by 55,869 shares in the reporting person's Form 4 report filed on December 21, 2018."}],"balance_after":111738,"source":{"system":"sec-edgar","filing":"0001140361-19-007695","document":"form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036119007695/form5.xml","form_type":"5"}},{"id":3682487,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-30T23:29:21.000Z","date":"2019-01-28","kind":"grant","acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 180,000 shares of the Issuer's Common Stock, 60,000 of which will become fully vested and exercisable on January 28, 2020, with the remaining 120,000 shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":180000,"derivative":{"exercise_price":14.56,"expiration_date":"2029-01-28","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001140361-19-002000","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036119002000/form4.xml","form_type":"4"}},{"id":3721044,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-21T22:00:43.000Z","date":"2018-12-20","kind":"exercise","acquired":true,"shares":55869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 167,607 shares of the Issuer's Common Stock 56,072 of which became fully vested and exercisable on April 18, 2017, with the remaining 111,535 shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":111738,"derivative":{"exercise_price":1.21,"expiration_date":"2026-04-18","underlying":"Common Stock","underlying_shares":55869},"source":{"system":"sec-edgar","filing":"0001140361-18-045651","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036118045651/form4.xml","form_type":"4"}},{"id":3721043,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-12-21T22:00:43.000Z","date":"2018-12-20","kind":"exercise","acquired":true,"shares":55869,"price":1.21,"value":67601.49,"ownership":{"direct":true},"balance_after":55869,"source":{"system":"sec-edgar","filing":"0001140361-18-045651","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036118045651/form4.xml","form_type":"4"}},{"id":3737409,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-12-10T22:01:04.000Z","date":"2018-12-06","kind":"purchase","acquired":true,"shares":5675,"price":14.98,"value":85011.5,"ownership":{"direct":false,"nature":"By spouse"},"balance_after":5675,"source":{"system":"sec-edgar","filing":"0001140361-18-044847","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036118044847/form4.xml","form_type":"4"}},{"id":3976179,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":79378,"kind":"person","name":"Patel Kinnari","position":1,"cik":"0001725929","reported_name":"Patel Kinnari","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-03T00:08:37.000Z","date":"2018-03-29","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 175,000 shares of the Issuer's Common Stock, 58,336 of which will become fully vested and exercisable on March 29, 2019, with the remaining 116,664 shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":175000,"derivative":{"exercise_price":18.75,"expiration_date":"2028-03-29","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0000899243-18-009113","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000089924318009113/doc4.xml","form_type":"4"}}]}